Newsroom

Industry News

7 Feb

Monster Digital, Inc. Announces New Management Appointments

SIMI VALLEY, CA–(Marketwired – Feb 7, 2017) – Monster Digital, Inc. ( NASDAQ : MSDI ) (“Monster Digital” or the “Company”), which develops, markets and distributes a line of sports action cameras, a 360 Virtual Reality camera and related VR Goggles under the Monster Digital brand, today announced new...

Read more

7 Feb

CymaBay Therapeutics to Present at the 2017 BIO CEO & Investor Conference

NEWARK, Calif., Feb. 07, 2017 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today announced that management will provide a corporate overview at the BIO CEO & Investor Conference, being held on February...

Read more

7 Feb

Actinium Pharmaceuticals Announces Pipeline Expansion with Initiation of Clinical Trial of Actimab-M in Multiple Myeloma

NEW YORK, Feb. 07, 2017 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc.  (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment options, announced today that a Phase 1 clinical trial studying Actimab-M in multiple myeloma has been initiated. Actimab-M is comprised...

Read more

7 Feb

MicroCap Review Magazine Winter/Spring 2017 Issue Now Available

LOS ANGELES, Feb. 7, 2017 /PRNewswire/ — SNN Incorporated, a global multimedia financial news and publishing company focused on the MicroCap stock market, and publisher of the MicroCap Review Magazine, is pleased to announce the release of the MicroCap Review Magazine Winter/Spring 2017 issue online and in print. The Winter/Spring...

Read more

7 Feb

Cellectar Biosciences to Present at 2017 BIO CEO & Investor Conference

MADISON, Wis., Feb. 07, 2017 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (CLRB), an oncology-focused, clinical stage biotechnology company, announced today that its president and CEO, Jim Caruso, will present at the 2017 BIO CEO & Investor Conference in on Monday, February 13th at 2:00 PM ET in the Windsor...

Read more

3 Feb

Intellipharmaceutics Announces FDA Acceptance for Filing of NDA for Rexista™ (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain

TORONTO, Feb. 02, 2017 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that the U.S. Food and Drug Administration (“FDA”) has accepted for...

Read more

Page 10 of 222« First...89101112...203040...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address